Recombinant human interleukin-2

{
  "id": "MLC-T-ONC-007254",
  "term": "Recombinant human interleukin-2",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat adults with melanoma or renal cell carcinoma (a type of kidney cancer) that has spread to other parts of the body. It is also being studied in the treatment of other types of cancer. Recombinant human interleukin-2 is a form of interleukin-2 that is made in the laboratory. Recombinant human interleukin-2 increases the activity and growth of white blood cells called T lymphocytes and B lymphocytes, which may help the immune system kill cancer cells. Recombinant human interleukin-2 is a type of cytokine and a type of immunomodulating agent. Also called aldesleukin and Proleukin.",
  "synonyms": [
    "aldesleukin",
    "Proleukin"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/recombinant-human-interleukin-2/"
}